TWINSTRAND THERAPEUTICS
Twinstrand Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of biological drugs for the treatment of life-threatening diseases. The product of the company is TST10088. It is a recombinant protein-based prodrug for activation by matrix metalloproteinases associated with solid tumor forms of cancer. Twinstrand is a Canada-based company that was founded in 1995. The company was acquired by Cangene on July 7, 2009.
TWINSTRAND THERAPEUTICS
Industry:
Biotechnology Health Care Information Technology Medical
Founded:
1995-01-01
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.twinstrand.com
Status:
Closed
Contact:
866-300-7602
Total Funding:
10 M CAD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator
Investors List
Western Technology Investment
Western Technology Investment investment in Venture Round - Twinstrand Therapeutics
MDS Capital
MDS Capital investment in Venture Round - Twinstrand Therapeutics
GrowthWorks Capital
GrowthWorks Capital investment in Venture Round - Twinstrand Therapeutics
Ensis Growth Fund
Ensis Growth Fund investment in Venture Round - Twinstrand Therapeutics
Official Site Inspections
http://www.twinstrand.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Twinstrand Therapeutics"
TwinStrand Biosciences - Crunchbase Company Profile & Funding
TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its …See details»
TwinStrand Biosciences
The inter-laboratory validation study indicated consistent results across laboratories (Health Canada and TwinStrand Biosciences). The findings in this study show that DS yields novel …See details»
Company - TwinStrand Biosciences
Company At TwinStrand, we are committed to applying a powerful new genomic technology across disciplines to improve human health and accelerate scientific discovery. Our mission is …See details»
TwinStrand Biosciences 2025 Company Profile: Valuation, Funding ...
TwinStrand Biosciences was founded in 2015. Where is TwinStrand Biosciences headquartered? TwinStrand Biosciences is headquartered in Seattle, WA. What is the size of TwinStrand …See details»
Our Team - TwinStrand Biosciences
Our Team Kissy (Karen) Dabbs JD General Counsel and Corporate Secretary Kissy (Karen) Dabbs JD General Counsel and Corporate Secretary Kissy is an attorney with more than 20 …See details»
TwinStrand Biosciences - LinkedIn
TwinStrand Biosciences Duplex Sequencing patent estate is the foundational technology enabling the ability to accurately identify ultra-low frequency genomic variants that are undetectable by ...See details»
TwinStrand Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Twinstrand Biosciences, Inc. - VentureRadar
TwinStrand Duplex Sequencing technology is an end-to-end solution, from pre-sequencing biochemistry to post-sequencing bioinformatics. Using standard sequencing systems and an …See details»
Twinstrand Therapeutics - Crunchbase Company Profile & Funding
Twinstrand Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of biological drugs for the treatment of life-threatening …See details»
TwinStrand Biosciences - Overview, News & Similar companies
Apr 25, 2024 SEATTLE--(BUSINESS WIRE)--TwinStrand Biosciences, Inc. (TwinStrand), the pioneer in Duplex Sequencing technology, which delivers clearer insights to researchers and …See details»
TwinStrand Biosciences Announces Leadership Transition
Oct 7, 2022 TwinStrand's scientist-leaders have authored more than two dozen peer-reviewed articles using Duplex Sequencing technology and have developed a portfolio of more than 150 patents and patent ...See details»
TwinStrand Biosciences - Craft
TwinStrand Biosciences is a company that develops Duplex Sequencing technology aimed at DNA sequencing. It tracks and compares strands of individual DNA molecules to eliminate …See details»
Company - TwinStrand Biosciences
Company We are a vibrant young company committed to applying a powerful new genomic technology across disciplines to improve human health and accelerate scientific discovery. …See details»
TwinStrand Biosciences Initiates Regulatory Approval Process for …
Apr 24, 2024 TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from genetic toxicology to …See details»
TwinStrand Biosciences - Contacts, Employees, Board Members, …
Organization. TwinStrand Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
TwinStrand Biosciences Initiates Regulatory Approval Process
Apr 24, 2024 TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from genetic toxicology to …See details»
News - TwinStrand Biosciences
Jun 6, 2022 TwinStrand Biosciences - February 24, 2022 National Firefighter Cancer Symposium 2022 This year we were proud to sponsor the scientific workshop Applying …See details»
TwinStrand Biosciences Announces $50 Million Series B to Expand …
May 6, 2021 TwinStrand's scientist-leaders have authored more than two dozen peer-reviewed articles using Duplex Sequencing Technology and have developed a portfolio of more than …See details»
TwinStrand Biosciences, Inc. et al v. Guardant Health, Inc. DC
Parties, patents and docket of University Of Washington v. Guardant Health Inc. (1:21-cv-01126) from District of Delaware filed on 08/03/2021See details»
Twinstrand Biosciences Inc. v. Guardant Health Inc. IPR of '221
PTAB case details and docket of Twinstrand Biosciences Inc. v. Guardant Health Inc. (IPR2022-01152), Inter Partes Review of patent US11118221B2 from Tech Center 1600 filed on …See details»